To: | Sunovion Pharmaceuticals Inc. (whiptrademark@wilmerhale.com) |
Subject: | U.S. Trademark Application Serial No. 88487127 - UCENTRO - 81277.349 |
Sent: | November 18, 2019 09:20:22 PM |
Sent As: | ecom125@uspto.gov |
Attachments: |
United States Patent and Trademark Office (USPTO)
Office Action (Official Letter) About Applicant’s Trademark Application
U.S. Application Serial No. 88487127
Mark: UCENTRO
|
|
Correspondence Address: |
|
Applicant: Sunovion Pharmaceuticals Inc.
|
|
Reference/Docket No. 81277.349
Correspondence Email Address: |
|
SUSPENSION NOTICE
No Response Required
Issue date: November 18, 2019
The application is suspended for the reason specified below. See 37 C.F.R. §2.67; TMEP §§716 et seq.
The pending application below has an earlier filing date or effective filing date than applicant’s application. If the mark in the application below registers, the USPTO may refuse registration of applicant’s mark under Section 2(d) because of a likelihood of confusion with the registered mark. 15 U.S.C. §1052(d); see 37 C.F.R. §2.83; TMEP §§1208.02(c). Action on this application is suspended until the prior-filed application below either registers or abandons. 37 C.F.R. §2.83(c). Information relevant to the application below was sent previously.
- U.S. Application Serial No. 88014395
Suspension process. The USPTO will periodically check this application to determine if it should remain suspended. See TMEP §716.04. As needed, the trademark examining attorney will issue a letter to applicant to inquire about the status of the reason for the suspension. TMEP §716.05.
No response required. Applicant may file a response, but is not required to do so.
Jaime Batt
/Jaime Batt/
USPTO Trademark Examining Attorney
Law Office 125
(571)-272-1125
jaime.batt@uspto.gov